|
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
1 |
1.000
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
1.000
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
1.000
|
|
|
|
regulation of somitogenesis
|
GO:0014807 |
6 |
1.000
|
|
|
|
regionalization
|
GO:0003002 |
337 |
1.000
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.999
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.999
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.999
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.999
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.999
|
|
|
|
negative regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045736 |
9 |
0.999
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.999
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.998
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.998
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.998
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.998
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.997
|
|
|
|
somite specification
|
GO:0001757 |
4 |
0.997
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.997
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.996
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.996
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.996
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.995
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.995
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.995
|
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.991
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.991
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.991
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.989
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.989
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.989
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.988
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.987
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.987
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.987
|
Human |
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.982
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.978
|
Human |
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.977
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.977
|
Human |
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.977
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.973
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.972
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.969
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.969
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.966
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.966
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.966
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.963
|
Human |
|
|
somitogenesis
|
GO:0001756 |
69 |
0.962
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.962
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.961
|
Worm |
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.961
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.960
|
|
|
|
macroautophagy
|
GO:0016236 |
21 |
0.960
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.958
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.956
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.955
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.955
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.955
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.955
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.950
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.948
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.944
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.944
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.943
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.943
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.942
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.941
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.939
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.938
|
Human |
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.936
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.935
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.929
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.929
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.925
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.924
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.923
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.919
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.919
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.918
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.916
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.915
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.912
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.912
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.909
|
Human |
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.907
|
|
|
|
regulation of microtubule polymerization
|
GO:0031113 |
7 |
0.904
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.902
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.900
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.898
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.897
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.891
|
|
|
|
mitotic cell cycle arrest
|
GO:0071850 |
4 |
0.888
|
Worm |
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.887
|
|
|
|
regulation of cohesin localization to chromatin
|
GO:0071922 |
1 |
0.887
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.885
|
Human |
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.879
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.878
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.868
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.867
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.867
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.862
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.861
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.856
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.853
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.853
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.850
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.849
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.849
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.846
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.840
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.838
|
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.837
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.837
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.835
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.833
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.831
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.822
|
Human |
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.821
|
|
|
|
regulation of photoreceptor cell differentiation
|
GO:0046532 |
4 |
0.819
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.819
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
18 |
0.817
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.816
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.814
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
18 |
0.813
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.810
|
|
|
|
negative regulation of auditory receptor cell differentiation
|
GO:0045608 |
2 |
0.806
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.801
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.794
|
|
|
|
cellular response to toxic substance
|
GO:0097237 |
7 |
0.793
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.792
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.792
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.791
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.788
|
|
|
|
positive regulation of rac protein signal transduction
|
GO:0035022 |
1 |
0.788
|
|
|
|
negative regulation of pancreatic a cell differentiation
|
GO:2000227 |
1 |
0.780
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.779
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.777
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.775
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.775
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.775
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.774
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.773
|
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.773
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.771
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.771
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.761
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.761
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.761
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.760
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.759
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.758
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.756
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.756
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.749
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.749
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.745
|
|
|
|
negative regulation of neurotransmitter secretion
|
GO:0046929 |
5 |
0.745
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.742
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.741
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.740
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.737
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.734
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.732
|
|
|
|
regulation of pro b cell differentiation
|
GO:2000973 |
5 |
0.730
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.730
|
Human |
|
|
negative regulation of epidermal cell differentiation
|
GO:0045605 |
7 |
0.728
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.728
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.726
|
|
|
|
anoikis
|
GO:0043276 |
6 |
0.718
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.716
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.713
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.711
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.709
|
|
|
|
negative regulation of oligodendrocyte differentiation
|
GO:0048715 |
11 |
0.704
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.699
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.698
|
Human |
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.695
|
Human |
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.694
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.694
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.693
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.690
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.690
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.686
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.683
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.677
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.677
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.674
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.673
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.671
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.658
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.656
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.652
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.651
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator
|
GO:0042771 |
24 |
0.650
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.649
|
|
|
|
epithelial cell proliferation involved in prostate gland development
|
GO:0060767 |
11 |
0.647
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.646
|
|
|
|
negative regulation of mechanoreceptor differentiation
|
GO:0045632 |
3 |
0.646
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.645
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.645
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.641
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.641
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.640
|
|
|
|
negative regulation of inner ear receptor cell differentiation
|
GO:2000981 |
3 |
0.639
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.638
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.637
|
|
|
|
negative regulation of glial cell differentiation
|
GO:0045686 |
21 |
0.636
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.634
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.634
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.633
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.632
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.631
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.628
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.628
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.627
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.624
|
Human |
|
|
stomach neuroendocrine cell differentiation
|
GO:0061102 |
2 |
0.623
|
|
|
|
segment specification
|
GO:0007379 |
15 |
0.622
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.622
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.621
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.620
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.618
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.617
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.608
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.603
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.602
|
|
|
|
negative regulation of epidermis development
|
GO:0045683 |
9 |
0.602
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.600
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.598
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.598
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.596
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.595
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.595
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.589
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.589
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.585
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.581
|
|
|
|
epithelial cell differentiation involved in prostate gland development
|
GO:0060742 |
13 |
0.581
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.575
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.571
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.571
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.570
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.569
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.567
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.563
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.562
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.560
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.560
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.559
|
Human |
|
|
regulation of inner ear receptor cell differentiation
|
GO:2000980 |
5 |
0.559
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.557
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
18 |
0.557
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.557
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.555
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.555
|
|
|
|
cohesin localization to chromatin
|
GO:0071921 |
1 |
0.551
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.550
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.543
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.540
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.538
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.537
|
|
|
|
proximal distal pattern formation involved in nephron development
|
GO:0072047 |
5 |
0.535
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.533
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.532
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.529
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.529
|
Human |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.519
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.518
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.516
|
Human |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.516
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.511
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.509
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.509
|
|
|
|
negative regulation of stomach neuroendocrine cell differentiation
|
GO:0061106 |
1 |
0.508
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.507
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.506
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.505
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.505
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.504
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.499
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.497
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.495
|
|
|
|
regulation of dna replication
|
GO:0006275 |
17 |
0.493
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.493
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.491
|
|
|
|
negative regulation of immature t cell proliferation
|
GO:0033087 |
3 |
0.490
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.490
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.490
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.487
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.485
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.484
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.483
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.481
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.481
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.480
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.480
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
21 |
0.477
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.477
|
|
|
|
regulation of protein import into nucleus translocation
|
GO:0033158 |
2 |
0.476
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.475
|
Worm |
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
22 |
0.473
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.472
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.472
|
|
|
|
blood vessel lumenization
|
GO:0072554 |
2 |
0.472
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.469
|
Human |
|
|
negative regulation of notch signaling pathway
|
GO:0045746 |
14 |
0.469
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.468
|
Human |
|
|
neuron maturation
|
GO:0042551 |
29 |
0.466
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.465
|
Human |
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.465
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.465
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.464
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.462
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase activity
|
GO:0043553 |
1 |
0.460
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.454
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.451
|
|
|
|
positive regulation of rap gtpase activity
|
GO:0032854 |
3 |
0.447
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.446
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.446
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.445
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.434
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.432
|
Human |
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.427
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.427
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.424
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.424
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.423
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.422
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.418
|
|
|
|
positive regulation of microtubule polymerization
|
GO:0031116 |
3 |
0.417
|
|
|
|
atrioventricular node development
|
GO:0003162 |
3 |
0.417
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.414
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.412
|
|
|
|
regulation of epithelial cell proliferation involved in prostate gland development
|
GO:0060768 |
10 |
0.412
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
3 |
0.409
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.408
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.408
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.406
|
|
|
|
pro b cell differentiation
|
GO:0002328 |
10 |
0.406
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.405
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.404
|
|
|
|
morphogenesis of an endothelium
|
GO:0003159 |
2 |
0.404
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.404
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.403
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.402
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.400
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.400
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.399
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.399
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.397
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.397
|
Human |
|
|
negative regulation of b cell proliferation
|
GO:0030889 |
13 |
0.397
|
|
|
|
negative regulation of fibroblast migration
|
GO:0010764 |
2 |
0.394
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.393
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.390
|
Human |
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.390
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.389
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.389
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.387
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.381
|
|
|
|
negative regulation of synaptic vesicle exocytosis
|
GO:2000301 |
3 |
0.378
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.375
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.374
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.373
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.370
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.370
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.366
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.365
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.365
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.364
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.363
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.363
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.362
|
|
|
|
monocyte differentiation
|
GO:0030224 |
9 |
0.358
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.358
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.358
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.358
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.353
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.350
|
|
|
|
regulation of sister chromatid cohesion
|
GO:0007063 |
5 |
0.349
|
Human |
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.349
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.348
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.348
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.347
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.347
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.346
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.344
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.343
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.343
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.342
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.341
|
|
|
|
positive regulation of autophagy
|
GO:0010508 |
9 |
0.338
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.335
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.335
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.335
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.330
|
|
|
|
positive regulation of keratinocyte differentiation
|
GO:0045618 |
3 |
0.330
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.329
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.329
|
Human |
|
|
mitochondrial dna repair
|
GO:0043504 |
3 |
0.329
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.328
|
|
|
|
regulation of anoikis
|
GO:2000209 |
2 |
0.328
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.327
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.326
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.325
|
|
|
|
positive regulation of mitotic cell cycle embryonic
|
GO:0045977 |
2 |
0.324
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.324
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.323
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.322
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.322
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
27 |
0.318
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.317
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.315
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.314
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.312
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.311
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.309
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.309
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.309
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.308
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.307
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.306
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.305
|
Human |
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.304
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.302
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.302
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.302
|
Human |
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.301
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.301
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.300
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.299
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.296
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.296
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.296
|
|
|
|
negative regulation of macroautophagy
|
GO:0016242 |
5 |
0.296
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.291
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.291
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.290
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.288
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.287
|
|
|
|
microtubule polymerization
|
GO:0046785 |
12 |
0.287
|
|
|
|
negative regulation of astrocyte differentiation
|
GO:0048712 |
10 |
0.287
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.283
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.282
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.282
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.281
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.280
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.278
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.276
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.276
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.275
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.274
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.274
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.273
|
|
|
|
endothelial tube morphogenesis
|
GO:0061154 |
2 |
0.272
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.271
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.271
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.271
|
|
|
|
negative regulation of tor signaling
|
GO:0032007 |
13 |
0.270
|
|
|
|
regulation of timing of neuron differentiation
|
GO:0060164 |
5 |
0.269
|
|
|
|
negative regulation of lipid kinase activity
|
GO:0090219 |
1 |
0.268
|
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.268
|
Human |
|
|
somite rostral caudal axis specification
|
GO:0032525 |
13 |
0.266
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.265
|
|
|
|
negative regulation of dendritic spine morphogenesis
|
GO:0061002 |
3 |
0.265
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.262
|
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.262
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.261
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.260
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.259
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.257
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.255
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.254
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.254
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.254
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.253
|
|